No movement because there was nothing "new" in today's news. Just a fluff pr restating what was already known and still no assurance of future financing. Maybe another Aspire deal, maybe a partnership, maybe dilution? (We know Leo prefers no dilution). SP won't move up with maybe's. 6th cohort beginning was the only real news but dosage was not given. We knew the 5th cohort was almost finished. This PR is all about maintaining SP. It' not a bad thing it's just nothing to get excited about. iMO